<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">persmed</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал персонализированной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal for Personalized Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2782-3806</issn><issn pub-type="epub">2782-3814</issn><publisher><publisher-name>ФОНД АЛМАЗОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2782-3806-2023-3-6-6-20</article-id><article-id custom-type="edn" pub-id-type="custom">ELYQYH</article-id><article-id custom-type="elpub" pub-id-type="custom">persmed-201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НЕЙРОХИРУРГИЯ</subject></subj-group></article-categories><title-group><article-title>Особенности кинетики роста доброкачественных нейроэпителиальных опухолей головного мозга у детей при рецидиве</article-title><trans-title-group xml:lang="en"><trans-title>Growth kinetics of benign neuroepithelial brain tumors in children with relapse</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федоров</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorov</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федоров Евгений Вадимович, врач-нейрохирург отделения нейрохирургии для детей </p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Fedorov Evgeniy V., pediatric neurosurgeon</p><p>Akkuratova str., 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ким</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ким Александр Вонгиевич, д.м.н., доцент, заведующий отделением нейрохирургии для детей</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Kim Alexander V., PhD, head of the department pediatric neurosurgery</p><p>Akkuratova str., 2, Saint Petersburg, 197341</p></bio><email xlink:type="simple">kimoza@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский&#13;
исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации; Научный центр мирового уровня «Центр персонализированной медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>01</month><year>2024</year></pub-date><volume>3</volume><issue>6</issue><fpage>6</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Федоров Е.В., Ким А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Федоров Е.В., Ким А.В.</copyright-holder><copyright-holder xml:lang="en">Fedorov E.V., Kim A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://persmed.elpub.ru/jour/article/view/201">https://persmed.elpub.ru/jour/article/view/201</self-uri><abstract><p>Проблему лечения детей с рецидивом церебральных опухолей невозможно решить без эффективного прогнозирования повторного бластоматозного роста. Основным вопросом будет, помимо возможных рисков рецидива опухоли, когда по времени следует ожидать повторный рост новообразования? Одним из вероятных путей в решении этой проблемы, на наш взгляд, является изучение кинетики роста опухолей и создание на ее основе математической модели. Цель исследования – проанализировать кинетические особенности продолженного роста доброкачественных нейроэпителиальных опухолей головного мозга у детей после хирургического лечения. В исследование включены результаты МРТ 32 пациентов в возрасте до 17 лет. Всем больным впервые проведена резекция опухоли головного мозга в отделении нейрохирургии для детей РНХИ им. проф. А. Л. Поленова (филиал НМИЦ им. В. А. Алмазова). У всех пациентов выявлен рецидив/продолженный рост опухоли, а также доброкачественный характер новообразования, подтвержденный патоморфологически. Для построения кинетических кривых использованы волюмометрические показатели опухолей, полученные при виртуальном 3D-моделировании. В зависимости от гистотипа определялась скорость роста опухоли по формуле: v = (VT-VO)/T, и проводилась графическая оценка изменений объема новообразования – построение кинетических кривых. Далее выявлены наиболее типичные кинетические кривые для каждого гистологического типа доброкачественных нейроэпителиальных опухолей.</p></abstract><trans-abstract xml:lang="en"><p>The problem of treating children with recurrent cerebral tumors cannot be solved without effective prediction of recurrent blastomatous growth. The main question will be, in addition to the possible risks of tumor recurrence, when should regrowth of the neoplasm be expected in time? In our opinion, one of the probable ways to solve this problem is to study the kinetics of tumor growth and create a mathematical model for it. The aim of the study was to analyze the kinetic features of the continued growth of benign neuroepithelial brain tumors in children after surgical treatment. The study included the results of an MRI of a 32 patients under the age of 17 years. All patients underwent brain tumor resection for the first time in the Department for Children Polenov Neurosurgical Institute (Almazov National Medical Research Centre). All patients had a relapse/continued tumor growth, as well as a benign nature of the neoplasm, which was confirmed pathomorphologically. To construct the kinetic curves, volumetric indicators of tumors obtained by virtual 3D-modeling were used. Depending on the histotype, the tumor growth rate was determined by the formula: v = (VT-VO)/T, and a graphical assessment of changes in the volume of the neoplasm was carried out – the construction of kinetic curves. Further, the most typical kinetic curves for each histological type of benign neuroepithelial tumors were identified.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>детская нейроонкология</kwd><kwd>доброкачественные глиомы у детей</kwd><kwd>кинетика роста доброкачественных глиом у детей</kwd><kwd>рецидив опухоли головного мозга у детей</kwd><kwd>скорость роста доброкачественных глиом</kwd><kwd>3D-моделирование опухолей головного мозга</kwd></kwd-group><kwd-group xml:lang="en"><kwd>growth kinetics pediatric low-grade gliomas</kwd><kwd>low-grade glioma growth rate</kwd><kwd>pediatric low-grade gliomas</kwd><kwd>pediatric neuro-oncology</kwd><kwd>recurrent brain tumors in children</kwd><kwd>3D modeling of brain tumors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров Е.В., Базархандаева Т.Б., Дон А.О. и др. «Клинические маски» нейроэпителиальных опухолей головного мозга у детей. В кн.: Воронцовские чтения. Санкт-Петербург-2020. Сборник материалов XIII Всероссийской научно-практической конференции с международным участием. Санкт-Петербургское региональное отделение общественной организации «Союз педиатров России». СПб, 2020: 42–43.</mixed-citation><mixed-citation xml:lang="en">Федоров Е.В., Базархандаева Т.Б., Дон А.О. и др. «Клинические маски» нейроэпителиальных опухолей головного мозга у детей. В кн.: Воронцовские чтения. Санкт-Петербург-2020. Сборник материалов XIII Всероссийской научно-практической конференции с международным участием. Санкт-Петербургское региональное отделение общественной организации «Союз педиатров России». СПб, 2020: 42–43.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ким А.В., Федоров Е.В., Шевцов М.А., Хачатрян В.А. Некоторые особенности рецидивирования нейроэпителиальных опухолей головного мозга у детей. Российский нейрохирургический журнал им. проф. А. Л. Поленова. 2020;12(2):9–16.</mixed-citation><mixed-citation xml:lang="en">Ким А.В., Федоров Е.В., Шевцов М.А., Хачатрян В.А. Некоторые особенности рецидивирования нейроэпителиальных опухолей головного мозга у детей. Российский нейрохирургический журнал им. проф. А. Л. Поленова. 2020;12(2):9–16.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Freeman C, Farmer J, Montes J. Low-grade astrocytomas in children: Evolving management strategies. Int J Radiat Oncol Biol Phys. 1998;41:979–987. https://doi.org/10.1016/S0360-3016(98)00163-1</mixed-citation><mixed-citation xml:lang="en">Freeman C, Farmer J, Montes J. Low-grade astrocytomas in children: Evolving management strategies. Int J Radiat Oncol Biol Phys. 1998;41:979–987. https://doi.org/10.1016/S0360-3016(98)00163-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman J, Soloniuk D, Humphreys R, et al. Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. Neursurgery. 1993;33:964–971.</mixed-citation><mixed-citation xml:lang="en">Hoffman J, Soloniuk D, Humphreys R, et al. Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. Neursurgery. 1993;33:964–971.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lazareff JA, Suwinski R, De Rosaa R, Olmstead CE. Tumor Volume and Growth Kinetics in Hypothalamic-Chiasmatic Pediatric Low Grade Gliomas.Pediatr Neurosurg. 1999;30:312–319. https://doi.org/10.1159/000028817</mixed-citation><mixed-citation xml:lang="en">Lazareff JA, Suwinski R, De Rosaa R, Olmstead CE. Tumor Volume and Growth Kinetics in Hypothalamic-Chiasmatic Pediatric Low Grade Gliomas.Pediatr Neurosurg. 1999;30:312–319. https://doi.org/10.1159/000028817</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">На грани химии и биологии: Сб. / Сост. Л. А. Устинова. М.: Знание. 1982. 64 с.</mixed-citation><mixed-citation xml:lang="en">На грани химии и биологии: Сб. / Сост. Л. А. Устинова. М.: Знание. 1982. 64 с.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Laird AK. Dynamics of tumor growth. Br J Cancer. 1964;13:490–502. https://doi.org/10.1038/bjc.1964.55</mixed-citation><mixed-citation xml:lang="en">Laird AK. Dynamics of tumor growth. Br J Cancer. 1964;13:490–502. https://doi.org/10.1038/bjc.1964.55</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nakasu S, Nakasu Y, Fukami T, et al. K. Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol. 2011;102(2):303–310. https://doi.org/10.1007/s11060-010-0319-1</mixed-citation><mixed-citation xml:lang="en">Nakasu S, Nakasu Y, Fukami T, et al. K. Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol. 2011;102(2):303–310. https://doi.org/10.1007/s11060-010-0319-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Henscheid N, Clarkson E, Myers KJ, Barrett HH. Physiological random processes in precision cancer therapy. Published: June 29, 2018. https://doi.org/10.1371/journal.pone.0199823</mixed-citation><mixed-citation xml:lang="en">Henscheid N, Clarkson E, Myers KJ, Barrett HH. Physiological random processes in precision cancer therapy. Published: June 29, 2018. https://doi.org/10.1371/journal.pone.0199823</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nahed BV, Redjal N, Brat DJ, et al. Management of patients with recurrence of diffuse low grade glioma A systematic review and evidence-based clinical practice guideline J Neurooncol. 2015;125:609–630. https://doi.org/10.1007/s11060-015-1910-2</mixed-citation><mixed-citation xml:lang="en">Nahed BV, Redjal N, Brat DJ, et al. Management of patients with recurrence of diffuse low grade glioma A systematic review and evidence-based clinical practice guideline J Neurooncol. 2015;125:609–630. https://doi.org/10.1007/s11060-015-1910-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Schiebe M, Ohneseit P, Hoffman W, et al. Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. J. Neurooncol. 2000;49(3):197–203. https://doi.org/10.1023/A:1006410702284</mixed-citation><mixed-citation xml:lang="en">Schiebe M, Ohneseit P, Hoffman W, et al. Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. J. Neurooncol. 2000;49(3):197–203. https://doi.org/10.1023/A:1006410702284</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Skipper H, Schabel FJr, Wilcox S. Experimental evaluation of potential anticancer agents XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother Rep. 1964;35:1.</mixed-citation><mixed-citation xml:lang="en">Skipper H, Schabel FJr, Wilcox S. Experimental evaluation of potential anticancer agents XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother Rep. 1964;35:1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Collins V, Loeffier R, Tivey H. Observations on growth rates of human tumors. Am. J. Roentgenol. 1956;76(5):988–1000.</mixed-citation><mixed-citation xml:lang="en">Collins V, Loeffier R, Tivey H. Observations on growth rates of human tumors. Am. J. Roentgenol. 1956;76(5):988–1000.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272–94.</mixed-citation><mixed-citation xml:lang="en">Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272–94.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yamashita T, Kuwabara T. Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol. 1983;20(6):464–470.</mixed-citation><mixed-citation xml:lang="en">Yamashita T, Kuwabara T. Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol. 1983;20(6):464–470.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lazareff JА, Suwinski R, De Rosaa R, Olmstead C. Tumor Volume and Growth Kinetics in Hypothalamic-Chiasmatic Pediatric Low Grade Gliomas. Pediatr Neurosurg. 1999;30(6):312–9. https://doi.org/10.1159/000028817</mixed-citation><mixed-citation xml:lang="en">Lazareff JА, Suwinski R, De Rosaa R, Olmstead C. Tumor Volume and Growth Kinetics in Hypothalamic-Chiasmatic Pediatric Low Grade Gliomas. Pediatr Neurosurg. 1999;30(6):312–9. https://doi.org/10.1159/000028817</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rees J, Watt H, Jäger HR, et al. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol. 2009;72(1):54–64. https://doi.org/10.1016/j.ejrad.2008.06.013</mixed-citation><mixed-citation xml:lang="en">Rees J, Watt H, Jäger HR, et al. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol. 2009;72(1):54–64. https://doi.org/10.1016/j.ejrad.2008.06.013</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kirkwood T. Deciphering death: a commentary on Gompertz (1825) “On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies”. Published:19 April 2015. https://doi.org/10.1098/rstb.2014.0379</mixed-citation><mixed-citation xml:lang="en">Kirkwood T. Deciphering death: a commentary on Gompertz (1825) “On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies”. Published:19 April 2015. https://doi.org/10.1098/rstb.2014.0379</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Laird AK. Dynamics of tumor growth. Br J Cancer. 1964;13:490–502. https://doi.org/10.1038/bjc.1964.55</mixed-citation><mixed-citation xml:lang="en">Laird AK. Dynamics of tumor growth. Br J Cancer. 1964;13:490–502. https://doi.org/10.1038/bjc.1964.55</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Railo M, Nordling S, von Boguslawsky K, et al. Prognostic value of Ki-67 immunolabeling in primary operable breast cancer. Br J Cancer. 1993;68:579 https://doi.org/10.1038/bjc.1993.389</mixed-citation><mixed-citation xml:lang="en">Railo M, Nordling S, von Boguslawsky K, et al. Prognostic value of Ki-67 immunolabeling in primary operable breast cancer. Br J Cancer. 1993;68:579 https://doi.org/10.1038/bjc.1993.389</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Norton L. Mathematical interpretation of tumor growth kinetics. In: Greenspan EM, editor. Clinical interpretation and practice of cancer chemotherapy. New York: Raven; 1982:53–70.</mixed-citation><mixed-citation xml:lang="en">Norton L. Mathematical interpretation of tumor growth kinetics. In: Greenspan EM, editor. Clinical interpretation and practice of cancer chemotherapy. New York: Raven; 1982:53–70.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931–4.</mixed-citation><mixed-citation xml:lang="en">Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931–4.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gilwski T, Norton L. Cytokinetics of neoplasia. In: The molecular basis of cancer. Mendelson J, Howley P, Israel M. (Eds), Saunders, Philadelphia. 1995:143–59.</mixed-citation><mixed-citation xml:lang="en">Gilwski T, Norton L. Cytokinetics of neoplasia. In: The molecular basis of cancer. Mendelson J, Howley P, Israel M. (Eds), Saunders, Philadelphia. 1995:143–59.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
